Skip to main content
American Journal of Public Health logoLink to American Journal of Public Health
. 2015 Oct;105(10):e12–e19. doi: 10.2105/AJPH.2015.302720

The Rationalization of Unethical Research: Revisionist Accounts of the Tuskegee Syphilis Study and the New Zealand “Unfortunate Experiment”

Charlotte Paul 1,, Barbara Brookes 1
PMCID: PMC4568718  PMID: 26270295

Abstract

Two studies, widely condemned in the 1970s and 1980s—the Tuskegee study of men with untreated syphilis and the New Zealand study of women with untreated carcinoma in situ of the cervix—received new defenses in the 21st century.

We noted remarkable similarities in both the studies and their defenses. Here we evaluate the scientific, political, and moral claims of the defenders.

The scientific claims are largely based on incomplete or misinterpreted evidence and exaggeration of the uncertainties of science. The defenders’ political arguments mistakenly claim that identity politics clouded the original critiques; in fact such politics opened the eyes of the public to exploitation. The moral defenses demonstrate an overreliance on codes of conduct and have implications for research ethics today.


In Dark Medicine: Rationalizing Unethical Medical Research, William LaFleur describes how rationalizations initially masquerade as reasons—but they are insufficient or invalid.1 Even Nazi physicians experimenting in the concentration camps rationalized their actions. These acts were grossly immoral, yet behind them were moral justifications. Those involved used these justifications to suppress and subdue their moral intuitions.2 These were rationalizations offered at the time, but such justifications can also be made in the present for the past actions of others, though the motives for doing so are different. We use the idea of rationalization to explore recent revisionist accounts of what have been widely regarded as unethical medical studies.

The Tuskegee syphilis study in Macon Country, Alabama, has been described as an egregious case of blatant racism.3 Nevertheless, it has always had its defenders, such as those who rushed to justify it when the study first came to public attention in the 1970s.4 In the 21st century, physician Robert White and cultural anthropologist Richard Shweder have proffered a fresh defense, suggesting that the study was neither unethical nor racist.5 Similarly, by the late 1980s a cervical precancer study in Auckland, New Zealand, was widely considered to be emblematic of unethical research and of the failures of professional self-regulation.6 This “unfortunate experiment”7 at the National Women’s Hospital had many similarities to the Tuskegee study. Defense of the unfortunate experiment is not new,8 but the established accounts of the study, that women with carcinoma in situ (CIS) of the cervix9 were followed but not treated, have recently been described as misjudged, both factually and ethically.10

The status afforded these new accounts is important. The Tuskegee and New Zealand studies have provided models of unethical practice for a generation of physicians and researchers. The US Belmont Report was prompted by the Tuskegee study revelations.11 The New Zealand cervical cancer study was subject to a judicial inquiry and report (the Cartwright Inquiry),12 and the subsequent recommendations led to wide-ranging changes in that country, including a legally enforceable code of patients’ rights and the appointment of a health and disability commissioner with powers to investigate complaints of breaches of the code.13

It would be wrong to exaggerate the importance of the new defenses. Though a Lancet Infectious Diseases editorial in 2005 used White’s and Shweder’s revisionist accounts to question whether the Tuskegee study was unethical or racist,14 these interpretations have not been widely cited. Similarly, though the New Zealand Medical Journal carried an invited editorial by the defender of the cervical cancer study, historian Linda Bryder,15 and the Royal Society of London published an admiring review of Bryder’s book,16 elsewhere her work has been strongly criticized.17 The latest revelation about the involvement of Tuskegee investigator John Cutler in deliberately infecting people with gonorrhea and syphilis in Guatemala in the 1940s should have put an end to defenses of the ethics of those investigators.18 Nevertheless, as historian Susan Reverby points out about the Tuskegee study, “There is a truth to what actually happened, and trying to understand it does matter.” She says that the revisionists’ arguments should be considered, “if for no other reason than to understand why they are being made.”19

Here we provide an overview, informed by the reports of the official inquiries, of the 2 studies’ similarities and differences.20 We draw on evidence from the original inquiries, historical accounts, and reports by the study investigators themselves to evaluate the scientific claims made by the defenders and explain their errors in reasoning. We also explore the political context in which the studies came to attention and the defenders’ moral claims.

Although the studies began in different historical periods (1932 in Alabama, 1966 in New Zealand), they came to light at a similar time (1970s and 1980s), and the revisionist accounts were written at a similar period (the first decade of the 21st century). Examining the accounts together casts a light on the way rationalization of unethical practices in the past takes a particular form in our own day.

OVERVIEW OF STUDIES

In 1932 in Macon County, Alabama, the US Public Health Service (USPHS) started a study of 400 African American men with latent or late syphilis who had not been treated. Men without syphilis (about 200) were also enrolled as control participants. The study was originally designed to last for 6 to 8 months, but it turned into a long-term study that continued for 40 years. The arsenic and bismuth compounds (metal therapy) used for treatment at the time were not offered to the men. The aims of the study were never clearly stated, but they certainly included documenting the natural course of untreated syphilis in African American men and examining whether the disease had a different course according to race. When penicillin became available in the 1940s and 1950s, this was also withheld.

In 1966, gynecologist Herbert Green, at National Women’s Hospital in Auckland obtained approval from the Hospital Medical Committee to withhold the conventional treatment used at the hospital (cone biopsy) from women with CIS of the cervix. His recorded aim was “to attempt to prove that CIS is not a pre-malignant disease.”21 This entailed following without treatment a selected group of women with a new diagnosis (obtained by a small “punch” biopsy) of CIS. The condition of the women with subsequent positive smears (indicating persistent disease) was monitored with repeated smears and biopsies to check for invasive cancer. Green wrote that he was attempting to “follow indefinitely patients with diagnosed but untreated lesions.”22 He withheld treatment, for varying lengths of time, from more than 100 women with CIS and microinvasive cancer of the cervix, vagina, and vulva.23

The similarities between these studies, which took place at different times and in different places, are striking. Both followed and recorded the natural course of untreated disease. They did not seek informed consent for this departure from normal care. Both continued for many years (1932–1972 in Alabama and 1966–1987 in New Zealand). The adverse outcomes for many of the participants were detailed in published reports before the studies were stopped. The investigators attempted to deny some participants treatment elsewhere.24 Many also received some treatment in the course of the studies. The studies were poorly run. Internal complaints (by Peter Buxton at the USPHS and physicians Bill McIndoe and Jock Mclean at National Women’s Hospital) led to internal inquiries that recommended continuation.25 Both studies ended only after journalists brought them to public notice.26 Finally, in neither case were criminal charges filed, but in both some compensation was eventually provided.27

The studies also had several relevant differences. No ethical review preceded the Tuskegee study, whereas the Hospital Medical Committee performed that function for Green’s study. The natural course of syphilis was followed until death (it seems fairly clear that men who developed symptoms of late syphilis remained untreated). By contrast, when women with CIS developed clinically invasive cancer (though not microinvasive cancer), they were offered treatment. The Tuskegee study clearly deceived participants: they were told they were receiving treatment when they were not. In the cervical cancer study, Green reassured women they did not need treatment to remove the lesion.28 Green misled his patients because he did not tell them that his view went against prevailing opinion, but arguably he did not deliberately deceive them because he believed what he told them. We have no evidence that the published results of the Tuskegee study were deliberately misrepresented, unlike in New Zealand, where Green misreported emerging results to look more favorable to his hypothesis.29 Few expressions of concern arose within the USPHS, whereas physicians at National Women’s Hospital made repeated complaints about Green’s study.

Research participants in both studies were relatively powerless: poor rural African Americans and urban public hospital patients in New Zealand’s largest city, including European, Maori, and Pacific Islands women, at a time when women were expected to be passive recipients of reproductive health care. But the men of Macon County, at a time of severe poverty, racial segregation, and almost no access to health services, were much more disadvantaged.30

Finally, the official inquiries into the 2 studies were very different. For the inquiry into the Tuskegee study, the US Department of Health, Education, and Welfare empaneled citizens representing medicine, law, religion, labor, education, health administration, and public affairs. The investigation was conducted less formally than the Cartwright Inquiry: some panel members went to Macon County to interview some of the men, and public hearings were held in Washington, DC. Set up in August 1972, it reported in April 1973. A minority report by Jay Katz contained stronger criticisms of the study. Subsequently, the Tuskegee panel was criticized for not adequately addressing some important facts, particularly the extent of deception, because panel members had no access to the early documents.31

By contrast, a district court judge, assisted by legal and medical advisers, conducted the Cartwright Inquiry. Six months of public hearings obtained evidence from numerous international and national experts. The inquiry subpoenaed relevant documents, examined all patients’ medical records, and interviewed 81 patients or relatives. Almost all parties had legal representation. Set up in June 1987, the inquiry reported in July 1988.

Just as the studies themselves had similarities and differences, so do the nature of the defenses. Shweder largely confines himself to questioning the received account of the Tuskegee study (and pointing out the myths) and is receptive to debate. White puts forward alternative evidence on empirical matters but accepts some of the received account, including the charge that the men were deceived. Bryder goes further in her discussions of the cervical cancer study, arguing against almost every aspect of the received account.

SCIENTIFIC CLAIMS

The status of these claims has been addressed in detail elsewhere,32 so we summarize the claims and rebuttal for both studies here. First, the defenders assert that treatment at the time the studies started (and throughout their course) was of uncertain value and hazardous.33 In fact, the evidence available in 1932 indicated that treatment of latent syphilis with arsenic and bismuth compounds substantially reduced the risk of tertiary syphilis. The relevant USPHS cooperative clinical studies reports on treatment of latent syphilis were published in 1932 and 1933,34 and the Department of Health, Education, and Welfare panel relied on them. Progression to symptomatic, tertiary syphilis occurred in 2% to 5% of the treated group and 20% to 30% of the untreated group. Treatment with arsenic and bismuth carried significant risk, but was considered less harmful than not treating.35 In 1947 the Syphilis Study Group of the USPHS regarded treatment with arsenic and bismuth compounds as having proven value,36 though by then the Venereal Disease Division recommended penicillin because it offered the advantages of brevity and safety, and indirect evidence suggested that it would be effective against latent disease.37 Nevertheless, the supply of penicillin was still limited. By the mid-1950s, the USPHS recommended that penicillin should be used for all stages of syphilis.38 It is not plausible to propose that the study investigators, who worked for the USPHS, would have had clinical grounds for withholding penicillin from the Tuskegee men once it became available.

In the 1960s, the effectiveness of cervical screening in reducing the incidence of cervical cancer in a population was still a matter of dispute,39 but the effectiveness of treatment of CIS was not. In studies among women whose CIS remained untreated, 24% to 75% progressed to invasive cancer over up to 17 years,40 but treatment reduced the risk of developing invasive cancer to 1% to 2%.41

The defenders’ claims that both studies began in a climate of substantial scientific uncertainty about the balance of benefit versus harm are based on omission or misreading of the relevant evidence. In modern parlance, the alternatives were not in equipoise: the balance of benefits and harms favored treating according to the scientific standards of the time.

The second defense claim is that other, contemporaneous studies withheld treatment; hence these cases should not be singled out for criticism. A study of untreated latent syphilis, similar to the Tuskegee study, was published in 1948, and although White describes treatment as being “willfully and intentionally denied,”42 the study's investigators described their actions as “to permit patients older than 50 years to remain untreated.”43 The investigators conjectured that the harms of treatment might be greater than the benefits at that age, but the results led them to conclude that at least up to age 60 years, if patients were in good health, treatment should be offered. This study had less potential for bias than the earlier studies but showed similar effectiveness of treatment.44

Likewise, Bryder claimed that “the international medical press reported on many studies in which doctors followed up cases of CIS without treatment,” that “there were many follow-up studies of women diagnosed with CIN1, CIN2, CIN3 (CIS),” and that “there was no shortage of studies but no definitive answers.”45 Yet none of the contemporary studies cited by Bryder was similar to Green’s study, except for a study of women with abnormal smears who were aged 20 or younger, an age group for which cervical screening was not recommended and where genuine uncertainty existed.46 Bryder conflated studies of follow-up of women after treatment with those of follow-up without treatment, and apparently comparable studies of withholding treatment enrolled women with lesser degrees of abnormality, in particular cervical dysplasia, in which the endpoint was CIS and the women gave informed consent.47 Therefore, claims that the studies were not unusual at the time demonstrate a lack of care in making comparisons.

The third claim the defenders make is that morbidity and mortality were not worse because of participation in the studies. Shweder asserts that no treatment would have been available to these men if they had not been part of the study, so they were not harmed by participation.48 Whether morbidity and mortality were worse for the men in the Tuskegee study does depend on whether they would have received treatment outside the study. Nevertheless, the conclusion of the investigators themselves was that the men were harmed. Published comparisons in the early years of the untreated Tuskegee men with treated men led the authors to conclude that

adequate antisyphilitic treatment prevented all forms of clinical relapse during the first 15 years of infection, whereas only one fourth of the Negros with untreated syphilis were normal.49

This demonstrates that the investigators believed that treatment was effective, and extrapolating from later studies, it is certain that lack of treatment among the Tuskegee men was seriously harmful.

Bryder’s case for the cervical cancer study is built around Green’s defense at the inquiry that his “conservative management” had been a “fortunate programme” because unnecessary surgery (removal of the lesion) was avoided.50 Bryder agrees that a later analysis showed harm in this approach, but asserts that this knowledge was not available at the time.51 In fact, ample evidence existed that women in Green’s study did worse than those who received standard treatment (cone biopsy) at the same hospital, starting with Green’s own publication in 1974.52 Moreover, far from benefiting from being spared treatment, many of the women in Green’s care were required to undergo multiple biopsies (each under general anesthetic) to check for invasion,53 more than 30 developed cancer, and at least 8 died.54 In both studies the relevant material is ignored or misinterpreted by the defenders.

POLITICAL CLIMATE

The revisionist accounts can be seen as part of a reassessment of, or backlash against, the change in intellectual climate between the 1960s and the 1990s, encompassing feminism and Black studies.55 A common idea in these movements is that subtle oppression and exploitation is ubiquitous, and in this period activists identified abuses in many areas of modern society that had traditionally been perceived as benign. The backlash emphasizes the excesses of these movements or misreads what is at stake. Surveying the scene in the United States, Daniel Rodgers observes that some of those reacting against these new movements saw in them nothing short of a collapse of truth. Abandon the ground of moral reasoning, the argument goes, and “all that was left was the play of power and identity politics.”56 In line with such critiques, the defenders of the original studies contend that the politics of oppression originally led African Americans and feminists to misread the scientific evidence to advance political ends. They claim that political activists sought to rescue the untold stories of poor African American men and of unsuspecting women.

To White, Shweder, and Bryder, these stories are suspect: they flow from “rhetoric” not “reason,”57 or emotion instead of reason. Bryder argues that the Cartwright Inquiry was driven by a feminist agenda because Cartwright said she conducted the inquiry “as a feminist and as a lawyer.”58 Bryder, in an interview, said that Judge Cartwright misunderstood the evidence, was confused, and got it wrong: “She was interviewing women who had cancer—now it’s a horrible disease and she is a very sympathetic listener and I think she was taken by that.”59 Of the defenders themselves, White is African American and Bryder is a woman; perhaps such defenses are more convincing coming from members of the affected groups.

It was indeed the case that, at times, identity politics got out of hand in the responses to publicity about both studies. The wrongs revealed were sometimes exaggerated to create new myths. Thus, a survey in 1999 found that 80% of African Americans believed that the Tuskegee men had been injected with syphilis.60 Furthermore, because of the complexity of both syphilis and cervical cancer, it is unsurprising that many people wrongly assumed, after the studies were exposed, that all latent syphilis would progress to death without treatment or that all untreated CIS would progress to invasive cervical cancer, when in fact over 20 years only about 30% to 50% of people with either disease would have had their condition progress.61

In the New Zealand case it did not help that the Cartwright Inquiry’s long title referred to “allegations concerning the treatment of cervical cancer”62; in fact it was the precursor of this condition that Green failed to treat. This may have led Iain Chalmers, a prominent epidemiologist, to his initial belief that all the women in Green’s study had cervical cancer (not CIS) at the outset. When Chalmers discovered this was not so, he wanted to clear a “totally unjustified slur” that arose when Green’s study was

referred to in the same breath as the scandalous long-term study of untreated syphilis in poor black sharecroppers in Tuskegee, Alabama.63

Chalmers may have assumed a qualitative difference between the studies: in one, disease was left untreated and in the other, a precursor, but not the disease of interest itself, was left untreated.

The closing submission to the Cartwright Inquiry by the Ministry of Women’s Affairs expanded Green’s wrongs to the whole of the medical profession:

Ultimately the issues are who controls medicine and how, about who benefits from it and who are its victims. Thus as so many witnesses have clearly stated, the central issue, above all others, is power.64

Statements such as this caused some people to think that the inquiry was simply a vehicle to wrest power away from the medical profession. An early defender of Green responded to criticism of her own claims in a piece entitled “Have You Been Burned at the Stake Yet?”65

The rhetoric of those who made exaggerated claims about the wrongs of the Tuskegee and New Zealand studies may have encouraged recent commentators to see African American and feminist health activists as wrong on all counts. These defenders therefore suspect that the studies themselves received unfair press coverage at the hands of polemicists, who were not to be trusted. In an effort to rescue the physicians found to be at fault in both studies, the defenders highlight evidence that might exculpate them and explain their actions. For White, this involves emphasizing the role of African American health workers; Bryder highlights the agency of Green’s patients (meanwhile ignoring the fact that although they had been referred to his care for the best available treatment, they were unknowingly denied it). Yet neither of these positions materially supports White's and Bryder’s claims that the original critiques of the studies were clouded by politics and that once the clouds were cleared little of substance remained.

Defending the studies may also speak to a desire to create a more comfortable medical and national narrative in which progress and the uncertainties of science are the touchstones and medicine evolves in step with society. As Reverby writes, “how easily medical uncertainty masks ethical blindness.”66 In both Shweder's and Bryder’s accounts, claimed uncertainty is used to exculpate the key actors.

MORAL ARGUMENTS

The defenders’ key moral claims are that the studies, at the time, did not violate medical research codes; that they were medically acceptable; and that, for Tuskegee, participants were not harmed because treatment was unavailable outside the study for such men.

By contrast, the official inquiries concluded that the studies were ethically wrong in proceeding without informed consent and in inflicting harms that could have been anticipated, for no commensurate benefit. Katz argued in his minority report in 1973 that the most fundamental reason for condemning the Tuskegee study at its inception was not that all participants should have been treated—some might not have wished to be treated—

but rather that they were never fairly consulted about the research project, its consequences for them, and the alternatives available to them.67

Similarly, Cartwright concluded that

had patients been . . . informed of the types of treatment available to them, informed of the risks of procedures which were not conventional, definitive treatment for carcinoma in situ, and given the opportunity freely to decide whether or not to be part of the trial, then the trial could not be so severely criticised.68

The defenders argue that standards of consent were not violated because “in 1932 the concept of informed consent had not even been imagined by medical professionals,”69 no written standards for experimentation existed in the 1930s,70 and the existing Helsinki Declaration gave “a strong exemption for patient consent in therapeutic research.”71 Furthermore, they argue that the behavior of the researchers was widely acceptable at the time. Shweder points out that doctors in the 1930s did not disclose information because of a benign paternalism that kept their eyes “fixed on some imagined greater good.”72 Bryder argues that Green’s relationship with his patients was little different from that of other medical professionals of his era. She writes,

Like others, Green stressed a confident approach: “. . . if the physician does not worry too much about the disease then neither will the patient!”73

The defenders are wrong in their interpretation of the ethical codes, wrong in not knowing about codes and principles of conduct in existence before these studies were instigated, and wrong that this behavior was widely acceptable at the time. In the United States, attempts to regulate medical research and to develop codes of practice began years before the Tuskegee study started.74 In 1907, a group that included the philosopher William James urged the passage of a bill to ensure “that no experiment should be performed in any other human being without his intelligent written consent.”75 In 1928, Harvard professor of medicine Richard C. Cabot argued that

experimentation upon a human being without his consent and without the expectation of benefit to him is without any ethical justification.76

Ethical guidelines for human experimentation, requiring consent, were issued by the government in Germany in 1931.77 The Declaration of Helsinki was promulgated before Green’s study, but Bryder misreads the declaration in claiming that it gives “strong exemption” for patient consent.78

Even if the defenders were right that the actions of the Tuskegee and New Zealand researchers were not forbidden by codes of research ethics, and were broadly accepted at the time, the question would become whether and how one should make moral judgments in the absence of agreed sanctions.

The defenders claim that research ethics cannot be judged except according to written codes of conduct. This cannot be the case. Historically, codes of conduct worked to codify existing practices—or existing aspirations. The Helsinki Declaration explicitly mentions older professional obligations: “The health of my patients shall be my first consideration.”79 From Hippocrates to Claude Bernard in the 19th century to our own day, tradition gives primacy to a morality for medicine as the science and art of healing. For centuries, medicine has been understood by practitioners and lay people to involve not only knowledge and skills, but also the application of these in the service of important moral ends. Drawing on this long tradition, Edmund Pellegrino describes the medical profession as a moral community by virtue of several characteristics:

The inequality of the medical relationship, the nature of medical decisions, the nature of medical knowledge and the ineradicable moral complicity of the physician in whatever happens to his patient.80

Contemporary physicians made moral critiques of both studies during their progress. Two physicians wrote to investigators in the Tuskegee study after reading published reports of the study. In 1955 Count D. Gibson wrote,

It seems to me that the continued observation of an ignorant individual suffering with a chronic disease for which therapeutic measures are available, cannot be justified on the basis of any accepted moral standard.81

He mentioned Hippocrates, Maimonides, and the American Medical Association Code of Ethics. In 1964 Irwin Schatz wrote, “I am utterly astounded by the fact that physicians allow patients with potentially fatal disease to remain untreated when effective therapy is available.”82 He called on the physicians associated with the study to reevaluate their moral judgments.

Similarly, in 1973 Green’s colleagues McIndoe and McLean wrote to the superintendent of National Women’s Hospital outlining their concerns about the harms to patients of Green’s management.83 These complaints led to an internal inquiry, and the subsequent publication of the results of Green’s study by McIndoe and McLean, together with Ron Jones and Peter Mullins,84 eventually brought the study to public notice.

A related claim is that these studies might be unethical by today’s standards, but they need to be understood in the sociocultural context and medical culture of their time. Certainly good historical inquiries can shed light on the social and medical environments that contributed to the formulation and continuation of these projects. In each of our examples, historical inquiry has demonstrated the ways the existing power structures made it very difficult to criticize the studies or to allow the criticism to lead to change.85 In the case of the poor African American sharecroppers in the American South, even African American doctors and nurses did not raise criticisms. At National Women’s Hospital, with female patients and male doctors, there is no record of a patient or a nurse complaining about Green. Formal complaints came only from physicians—and only from those outside the academic hierarchy.

Shweder also argues that the men with syphilis in the Tuskegee study were not worse off than their counterparts outside the study in the same situation in Macon County, because treatment was inaccessible to such people at that time.86 David Rothman pointed out the dangers in experiments that build on social deprivation, including the fact that they are likely to manipulate the consent of participants.87 And indeed this happened. Because the men were deceived into believing they were receiving treatment, they had no chance even to try to obtain medical care. There might have been justification for a short-term trial (with consent), investigating the conjectured harms of lack of treatment in African American men with latent and late syphilis and thus providing evidence on which to base treatment of all such men. But this was not the Tuskegee situation, and for the study to continue into the 1940s—let alone later—when outside the study people with syphilis in Macon County were being routinely offered treatment shows that Shweder’s justification cannot hold up.

By the 1970s and 1980s, the people outside the medical profession who brought the studies to public notice did not hesitate to judge them to be wrong. The moral resources they used to discern this were not new and not relative. It was obvious that the participants were treated as means to scientific ends by the investigators; that they were not told the truth, and even repeatedly lied to; and that they were subjected to avoidable harm. Perhaps it is a cramped morality, consisting only of formal obligations or rules and cut off from its source in moral intuitions, that blinds the defenders.88 In his reflections on experimenting on people, philosopher Hans Jonas cited the Golden Rule in its negative form: do not do unto others what you do not want done unto yourself.89 The exercise of the moral imagination should enable one to put oneself in the place of the participant in research. For the men in the USPHS, it was 1 step too far to imagine that the poor men of Macon County were just like them. Likewise, Green could not imagine that a woman might wish to make up her own mind about treatment options rather than trust to his (impaired) judgment. When Tuskegee investigator Sidney Olansky was asked about withholding penicillin, the interviewer asked, “Wouldn’t you have treated yourselves?” Yet Olansky replied, “I don’t know . . . It is a trick question.”90

The 2 studies came to public notice in the ferment of the civil rights movement and the women’s movement. Indeed, the explosion of moral insight and the determination that characterized these movements provided a climate in which the existing power structures could be defied and the unethical practices exposed to public view. Of course the effect of this exposure was not simply a benefit for medicine and research. The legacies of both Tuskegee and the New Zealand study have suffered abuses.91 Yet it is perhaps a sign of the different times that we live in now, when those social movements are no longer so strong, that the defenders’ arguments seem more acceptable.

A distinguished African American physician, Charles MacDonald, writing in 1974 in the Journal of the National Medical Association, picked up the sense of having one’s eyes opened:

In my opinion the greatest contribution of the Tuskegee Study lies not in the scientific merit of the publications that have emanated from it, but in the anguish and concern its revelation has provoked in the minds of lay persons, physicians, medical investigators and others . . . our entire nation has been stimulated to rethink and redefine our present day position and practices as they relate to human experimentation.”92

CONCLUSIONS

Even though we can appreciate the context in which these arguments in defense of the studies have emerged, they are mistaken in all substantive disagreements with the original critiques. In their attempt to explain and justify past medical research, the defenders have used existing power relations, overreliance on and limited interpretation of codes of conduct, confusion about scientific issues, and exaggeration of the uncertainties of science to make their case. In the end their accounts rely on an impoverished view of ethics: they have become whitewashes for studies that caused real harms.

Both studies came to light when existing power structures were under intense scrutiny from feminism and opposition to racism. Yet when the clouds of identity politics are cleared, we can see that they did not affect the substance of the original critiques. Moreover, the political focus on rescuing untold stories of African Americans and women enabled the wider public to see the racism and exploitation with fresh eyes.

Finally, the rationalizations tell us something important about research ethics today. Both the Tuskegee study and the unfortunate experiment deserve repeated revisiting because of the serious moral issues at stake. Yet retellings that rely too heavily on the existence and the authority of codes of ethics serve to reinforce a view that such codes are all that is necessary to protect vulnerable research participants. Their existence has not prevented institutional review board approval of studies today that are potentially exploitative.93 More than rules are required; as moral philosopher Jonathan Glover writes, a code of ethics “should include the imagination to look through the rules to the human reality.”94 Codes and guidelines are necessary, but they require thoughtful moral interpretation, alert to context.95 Those who rationalize mistakes made in the past impair our ability to make just decisions today.

Acknowledgments

We thank Jing-Bao Nie for very helpful discussion of the ethical issues and Joanna Manning, Tom Cunningham, and Ron Paterson for helpful comments on a previous draft.

Note. C. Paul was 1 of 3 medical advisers to the Cartwright Inquiry. She assisted in compiling the medical review for the Inquiry.

Human Participant Protection

Institutional review board approval was not needed because no human participants were involved.

Endnotes

  • 1. W. R. LaFleur, “Introduction: The Knowledge Tree and Its Double Fruit,” in Dark Medicine: Rationalizing Unethical Medical Research, ed. W. R. LaFleur, G. Bohme, and S. Shimazono (Bloomington, IN: Indiana University Press, 2007), 1–12.
  • 2. G. Bohme, “Rationalizing Unethical Research: Taking Seriously the Case of Viktor Von Weizsacker,” in Dark Medicine, 15–29.
  • 3. LaFleur, “Introduction.”.
  • 4. J. H. Jones, Bad Blood: The Tuskegee Syphilis Experiment (New York, NY: Free Press, 1981), 1–15.
  • 5. R. M. White, “Unraveling the Tuskegee Study of Untreated Syphilis,” Archives of Internal Medicine 160, no. 5(2000): 585–598; R. M. White, “Misrepresentations of the Tuskegee Study of Untreated Syphilis,” Journal of the National Medical Association 97, no. 12 (2005): 1729–1731; R. A. Shweder, “Tuskegee Re-examined: A Cultural Anthropologist Offers a Counter-narrative to the Infamous Story of US Government Scientists Allowing Black Men to Suffer from Untreated Syphilis,” Spiked January 8, 2004, http://www.spiked-online.com/Articles/0000000CA34A.htm (accessed April 17, 2012)
  • 6. A. V. Campbell, “A Report from New Zealand: An ‘Unfortunate Experiment,’” Bioethics 3, no. 1 (1989): 59–66. [DOI] [PubMed]
  • 7. S. Coney. The Unfortunate Experiment: The Full Story Behind the Inquiry Into Cervical Cancer Treatment (Auckland, New Zealand: Penguin Books NZ Ltd, 1988).
  • 8. J. Corbett, “Second Thoughts on the Unfortunate Experiment at National Women’s”, Metro Magazine, July 1990, 54–73.
  • 9. Now, with severe dysplasia, defined as cervical intraepithelial neoplasia 3 (CIN3).
  • 10. L. Bryder, A History of the “Unfortunate Experiment” at National Women’s Hospital (Auckland, New Zealand: Auckland University Press, 2009); L. Bryder, Women’s Bodies and Medical Science (Basingstoke, UK: Palgrave McMillan, 2010); L. Bryder, The Rise and Fall of National Women’s Hospital, a History (Auckland, New Zealand: Auckland University Press, 2014).
  • 11. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research (Washington, DC: US Dept of Health, Education, and Welfare, 1979). [PubMed]
  • 12. S. R. Cartwright, The Report of the Cervical Cancer Inquiry: The Report of the Committee of Inquiry into Allegations Concerning the Treatment of Cervical Cancer at National Women’s Hospital and Into Other Related Matters (Wellington, New Zealand: Government Printer, 1988). (Also known as the Cartwright Inquiry.)
  • 13. J. B. Nie and L. Anderson, “Bioethics in New Zealand: A Historical and Sociological Review,” in Annals of Bioethics, ed. J. F. Peppin and M. J. Cherry (Lisse, the Netherlands: Swetz and Zeitlinger, 2003), 341–361.
  • 14. “Clearing the Myths of Time: Tuskegee Revisited,” Lancet Infectious Diseases 5, no. 3 (2005), 127. [DOI] [PubMed]
  • 15. L. Bryder, “A Response to Criticisms of the History of the ‘Unfortunate Experiment’ at National Women's Hospital,” New Zealand Medical Journal 123, no. 1319 (2010): 14–21. [PubMed]
  • 16. R. W. Carrell, “Trial by Media,” Notes and Records of the Royal Society of London 66, no. 3 (2012): 301–306.
  • 17. C. Barton, “An Unfortunate Fallout: Academics Against Bryder’s Revisionist History,” New Zealand Herald, September 19, 2009, B2; B. Brookes, “The Making of a Controversy: History, Medicine and Politics,” in The Cartwright Papers: Essays on the Cervical Cancer Inquiry 1987–88, ed. J. Manning (Wellington, New Zealand: Bridget Williams Books, 2009), 100–117; S. Coney, “The Unfortunate History,” in Cartwright Papers, 139-148; C. Barton, “No Accounting for Mistakes,” New Zealand Herald, July 17, 2010, B6. For complaints to the publisher, see “Facts About the Cartwright Inquiry: The University of Auckland,” http://www.cartwrightinquiry.com/?page_id=31 (accessed April 7, 2014)
  • 18. US Dept of Health and Human Services, “Fact Sheet on the 1946–1948 US Public Health Service Sexually Transmitted Diseases Inoculation Study,” available at: http://www.hhs.gov/1946inoculationstudy/factsheet.html (accessed March 6, 2015)
  • 19. S. M. Reverby, Examining Tuskegee: The Infamous Syphilis Study and Its Legacy (Chapel Hill: University of North Carolina Press; 2009), 233.
  • 20. US Dept of Health, Education, and Welfare, Final Report of the Tuskegee Syphilis Study Ad Hoc Advisory Panel (Washington, DC: US Government Printing Office, 1973); Tuskegee Syphilis Study Legacy Committee, “Legacy Committee Request,” in Tuskegee Truths: Rethinking the Tuskegee Syphilis Study, ed. S. M. Reverby (Chapel Hill, NC: University of North Carolina Press, 2000), 559–566; “President William C. Clinton’s Remarks,” in Tuskegee Truths, 574–577; Cartwright, Report of the Cervical Cancer Inquiry.
  • 21. Cartwright, Report of the Cervical Cancer Inquiry, 21.
  • 22. G. H. Green, “Cervical Carcinoma In Situ,” Australian and New Zealand Journal of Obstetrics and Gynaecology 10, no.1 (1970), 41. [DOI] [PubMed]
  • 23. G. H. Green, “The Progression of Pre-Invasive Lesions of the Cervix to Invasion,” New Zealand Medical Journal 80, no. 525 (1974): 279–827; R. W. Jones and M. R. McLean, “Carcinoma In Situ of the Vulva: A Review of 31 Treated and Five Untreated Cases,” Obstetrics and Gynaecology 68 (1986): 499–503; Cartwright, Report of the Cervical Cancer Inquiry, 114. [PubMed]
  • 24. US Dept of Health, Education, and Welfare, Final Report of the Tuskegee Syphilis Study, 9-10; Cartwright, Report of the Cervical Cancer Inquiry, 50.
  • 25. US Dept of Health, Education, and Welfare, Final Report of the Tuskegee Syphilis Study, 10–11; Cartwright, Report of the Cervical Cancer Inquiry, 70–88.
  • 26. J. Heller, “Syphilis Victims in U.S. Study Went Untreated for 40 Years,” in Tuskegee Truths, 116–118; P. Bunkle and S. Coney, “An Unfortunate Experiment at National Women’s Hospital,” Metro Magazine, June, 1987, 46–65.
  • 27. F. Gray, “The Lawsuit,” in Tuskegee Truths, 473–488. In New Zealand the Accident Compensation Commission paid compensation.
  • 28. Green wrote, “close follow-up is not mentally traumatic to patients treated conservatively even to those with persistently positive smears—providing one can speak to the patient with confidence.” (Green, “Cervical Carcinoma In Situ,” 43.)
  • 29. Cartwright, Report of the Cervical Cancer Inquiry, 54–55.
  • 30. Jones, Bad Blood, 61–77.
  • 31. Reverby, Examining Tuskegee, 91–100.
  • 32. C. Paul, “Defenses of the Tuskegee Syphilis Study: Assessment of Empirical Claims.” Working Paper, July 17, 2015, http://www.otago.ac.nz/dsm/people/expertise/profile/?id=633 (accessed July21, 2015); C. Paul, “The Medical Context,” in Cartwright Papers, 118–38.
  • 33. R. M. White, “The Tuskegee Study of Untreated Syphilis Revisited,” Lancet Infectious Diseases 6, no. 2 (2006): 62–63; “Clearing the Myths of Time: Tuskegee Revisited,” Lancet Infectious Diseases 5, no. 3 (2005), 127; White, “Misrepresentations of the Tuskegee Study”; Bryder, History of the “Unfortunate Experiment,” 40. [DOI] [PubMed]
  • 34. J. E. Moore et al., “Latent Syphillis: Cooperative Clinical Studies in the Treatment of Syphilis,” Venereal Disease Information 13 (1932): 351–364; J. E. Moore et al., “Latent Syphilis: Cooperative Clinical Studies in the Treatment of Syphilis,” Venereal Disease Information 14(1933):1–56.
  • 35. J. E. Moore, The Modern Treatment of Syphilis [textbook, 1933], cited in “Racism and Research: The Case of the Tuskegee Syphilis Study,” Hastings Center Report 8 (1978): 21–29. For more detail, see Paul, “Defenses of the Tuskegee Syphilis Study: Assessment of Empirical Claims.”. [PubMed]
  • 36. L. A. Altshuler et al., “The Status of Penicillin in the Treatment of Syphilis, December 1, 1947,” Journal of the American Medical Association 136, no. 13(1948): 873–879. [PubMed]
  • 37. Venereal Disease Education Institute, Diagnosis and Treatment of Syphilis: A Handbook for Physicians (Raleigh, NC: Venereal Disease Division, US Public Health Service, 1948).
  • 38. VD Fact Sheet. No. 10 (Washington, DC: US Public Health Service, 1953), 20; VD Fact Sheet. (Washington, DC: US Public Health Service, 1960), 19.
  • 39. E. G. Knox, “Cervical Cytology: A Scrutiny of the Evidence,” in Problems and Progress in Medical Care: Essays on Current Research, Second Series, ed. G. McLachlan (London, UK: Oxford University Press, 1966), 279–309.
  • 40. A. I. Spriggs, “Precancerous States of the Cervix Uteri,” in Precancerous States, ed. R. L. Carter (London, UK: Oxford University Press, 1984), 317–355.
  • 41. P. Kolstad and V. Klem, “Long-Term Followup of 1121 Cases of Carcinoma In Situ,” Obstetrics and Gynecology 48 (1976): 125–129; F. E. Bryans et al., “The Cytology Program in British Columbia Part II. Management of Preclinical Carcinoma of the Cervix,” Canadian Medical Association Journal 90 (1964):62-70.
  • 42. White, “Unraveling the Tuskegee Study,” 595. [DOI] [PubMed]
  • 43. H. L. Blum and C. W. Barnett, “Prognosis in Late Syphilis,” Archives of Internal Medicine (Chicago) 82, no. 4 (1948): 393. [DOI] [PubMed]
  • 44. Paul, “Defences of the Tuskegee Syphilis Study.”.
  • 45. Bryder, History of the “Unfortunate Experiment,” 44, 46.
  • 46. J. E. MacGregor and S. Teper, “Uterine Cervical Cytology and Young Women,” Lancet 311, no. 8072 (1978): 1029–1031. [DOI] [PubMed]
  • 47. R. M. Richart and B. A. Barron, “A Follow-Up Study of Patients With Cervical Dysplasia,” Amercian Journal of Obstetrics and Gynecology 105, no 3 (1969): 386–393. [DOI] [PubMed]
  • 48. Shweder, “Tuskegee Re-Examined.”.
  • 49. R. A. Vonderlehr et al., “Untreated Syphilis in the Male Negro: A Comparative Study of Treated and Untreated Cases,” Journal of the American Medical Association 107, no. 11 (1936): 859.
  • 50. Bryder, History of the “Unfortunate Experiment,” 197. Confusingly, Green used “conservatively treated” to describe what he elsewhere called “untreated or incompletely treated.” See G. H. Green and J. W. Donovan, “The Natural History of Cervical Carcinoma In Situ,” Journal of Obstetrics and Gynaecology of the British Commonwealth 77, no. 1 (1970): 1–9. Normally the term is used to denote treatment that removes the lesion but conserves the uterus, e.g., cone biopsy and local methods to remove the lesion. [DOI] [PubMed]
  • 51. Bryder, History of the “Unfortunate Experiment,” 43.
  • 52. G. H. Green, “The Progression of Pre-invasive Lesions of the Cervix to Invasion,” New Zealand Medical Journal 80, no. 525 (1974): 279–287; W. A. McIndoe et al., “The Invasive Potential of Carcinoma In Situ of the Cervix,” Obstetrics and Gynecology 64, no. 4 (1984): 451–458; Cartwright, Report of the Cervical Cancer Inquiry, 235. [PubMed]
  • 53. Cartwright, Report of the Cervical Cancer Inquiry, 42-46.
  • 54. M. R. McCredie et al., “Consequences in Women of Participating in a Study of the Natural History of Cervical Intraepithelial Neoplasia 3,” Australian and New Zealand Journal of Obstetrics and Gynaecology 50, no. 4 (2010): 363–370. The incidence of invasive cancer was 10 times as high among the women who received only a punch or wedge biopsy as among women who received a cone biopsy or hysterectomy; almost all the deaths from cervical or vaginal vault cancer were among the former group. [DOI] [PubMed]
  • 55. D. T. Rodgers, Age of Fracture (Cambridge, MA: Belknap Press of Harvard University Press, 2011); T. Eagleton, After Theory (London, UK: Penguin Books, 2004).
  • 56. Rodgers, Age of Fracture, 176.
  • 57. White, “Unraveling the Tuskegee Study,” 597. [DOI] [PubMed]
  • 58. L. Bryder, “National Women’s,” New Zealand Listener, April 26, 2014, 6.
  • 59. Coney, “Unfortunate History,” 146.
  • 60. R. V. Katz et al., “The Legacy of the Tuskegee Syphilis Study: Assessing Its Impact on Willingness to Participate in Biomedical Studies. Journal of Health Care for the Poor and Underserved 19, no. 4 (2008): 1168–1180. [DOI] [PMC free article] [PubMed]
  • 61. M. R. Golden, C. M. Marra, and K. K. Holmes, “Update on Syphilis: Resurgence of an Old Problem,” Journal of the American Medical Association 290 (2003): 1510–1514; M. R. McCredie et al., “Natural History of Cervical Neoplasia and Risk of Invasive Cancer in Women With Cervical Intraepithelial Neoplasia 3: A Retrospective Cohort Study,” Lancet Oncology 9, no. 5(2008): 425–434. [DOI] [PubMed]
  • 62. Cartwright, Report of the Cervical Cancer Inquiry, 1.
  • 63. I. Chalmers, “Defendants of the Cartwright Inquiry Are Unable to Provide a Description of 'Adequate Care' for Cervical Carcinoma In Situ,” New Zealand Medical Journal 123, no. 1322 (2010), 86. [PubMed]
  • 64. Quoted in C. Paul, “Internal and External Morality of Medicine: Lessons From New Zealand,” BMJ 320, no. 7233 (2000), 500. [DOI] [PMC free article] [PubMed]
  • 65. J. Corbett, “Have You Been Burned at the Stake Yet?” Metro Magazine, October, 1990, 156–165.
  • 66. Reverby, Examining Tuskegee, 119.
  • 67. US Dept of Health, Education, and Welfare, Final Report of the Tuskegee Syphilis Study, 14.
  • 68. Cartwright, Report of the Cervical Cancer Inquiry, 136.
  • 69. Shweder, “Tuskegee Re-Examined.”.
  • 70. “Clearing the Myths of Time.”.
  • 71. Bryder, A History of the “Unfortunate Experiment,” 69.
  • 72. Shweder, “Tuskegee Re-examined.”.
  • 73. Bryder, A History of the “Unfortunate Experiment,” 62.
  • 74. R. R. Faden, T. L. Beauchamp, and N. M. King, A History and Theory of Informed Consent (New York: Oxford University Press, 1986); S. E. Lederer, Subjected to Science: Human Experimentation in America Before the Second World War (Baltimore, MD: Johns Hopkins University Press, 1995).
  • 75. Lederer, Subjected to Science, 75.
  • 76. Ibid, 123.
  • 77. J. Vollman and R. Winau, “Informed Consent in Human Experimentation Before the Nuremberg Code,” BMJ. 313, no. 7070 (1996): 1445–1449. [DOI] [PMC free article] [PubMed]
  • 78. J. R. Williams, “The Declaration of Helsinki and Public Health,” Bulletin of the World Health Organization 86, no. 8 (2008): 650–652; Bryder, A History of the “Unfortunate Experiment,” 69. [DOI] [PMC free article] [PubMed]
  • 79. Williams, “The Declaration of Helsinki and Public Health,” 650. [DOI] [PMC free article] [PubMed]
  • 80. E. D. Pellegrino, “The Medical Profession as a Moral Community,” Bulletin of the New York Academy of Medicine 66, no. 3 (1990), 226. [PMC free article] [PubMed]
  • 81. Quoted in Reverby, Examining Tuskegee, 70.
  • 82. Quoted in Reverby, Examining Tuskegee, 75.
  • 83. Cartwright, Report of the Cervical Cancer Inquiry, 70–75.
  • 84. McIndoe, “Invasive Potential of Carcinoma In Situ of the Cervix.”.
  • 85. Brandt, “Racism and Research,” Brookes, “Making of a Controversy.”.
  • 86. Shweder, “Tuskegee Re-examined.” Even this point is uncertain. In 1938 Vonderlehr wrote, “Adequate treatment [for syphilis] has not been freely available to most indigent people for more than ten to twelve years.” R. A. Vonderlehr, “A Comparison of Treated and Untreated Syphilis: The Efficacy of Modern Antisyphilitic Treatment,” Annual Bulletin John A Andrew Clinic 1 (1938): 41–52.
  • 87. D. J. Rothman, “Were Tuskegee & Willowbrook ‘Studies in Nature’?” Hastings Center Report 12, no. 2 (1982): 5–7. [PubMed]
  • 88. C. Taylor, Sources of Self: The Making of the Modern Identity (Cambridge, UK: Cambridge University Press, 1989).
  • 89. H. Jonas, “Philosophical Reflections on Experimenting With Human Subjects,” Daedalus 98, no. 2 (1969): 219–247.
  • 90. Reverby, Examining Tuskegee, 149.
  • 91. A. L. Fairchild and R. Bayer, “Uses and Abuses of Tuskegee,” Science 284 (1999): 919–921; Paul, “Internal and External Morality of Medicine.”. [DOI] [PubMed]
  • 92. C. J. MacDonald, “The Contribution of the Tuskegee Study to Medical Knowledge,” Journal of the National Medical Association 66, no. 1 (1974), 6. [PMC free article] [PubMed]
  • 93. C. Elliott, “The Big Selling, Billion-Dollar Pills Tested on Homeless People,” Matter, 2014, https://medium.com/matter/did-big-pharma-test-your-meds-on-homeless-people-a6d8d3fc7dfe (accessed December 1, 2014)
  • 94. J. Glover, Humanity: A Moral History of the Twentieth Century (New Haven, CT: Yale University Press, 2001), 393.
  • 95. S. R. Benatar, “Reflections and Recommendations on Research Ethics in Developing Countries,” Social Science and Medicine 54, no. 7 (2002): 1131–1141. [DOI] [PubMed]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES